North China Pharmaceutical Co (SHSE:600812) Ending Cash Position : ¥392 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co Ending Cash Position?

North China Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥392 Mil.

North China Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2023 (¥923 Mil) to Dec. 2023 (¥505 Mil) and declined from Dec. 2023 (¥505 Mil) to Mar. 2024 (¥392 Mil).

North China Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (¥5,049 Mil) to Dec. 2022 (¥1,055 Mil) and declined from Dec. 2022 (¥1,055 Mil) to Dec. 2023 (¥505 Mil).

North China Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for North China Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

North China Pharmaceutical Co Ending Cash Position Chart

North China Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1,135.55

4,466.39

5,048.81

1,054.57

505.01

North China Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,432.54	1,002.81	923.39	505.01	392.49

North China Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

North China Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1054.568	+	-549.563
	=	505

North China Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	505.004	+	-112.514
	=	392

North China Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of North China Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

North China Pharmaceutical Co (SHSE:600812) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015

Website

http://www.ncpc.com

North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.

Executives

Gao Ren Long	senior management
Lian Fa Zhe	Director

North China Pharmaceutical Co (SHSE:600812) Headlines

No Headlines